
SNYR Stock Forecast & Price Target
SNYR Analyst Ratings
Bulls say
Synergy CHC is poised for future growth with strong Q4 results, a focus on new products and international expansion, and an undervalued valuation. While facing competition and regulatory challenges, the company's FOCUSfactor brand has shown significant growth and its presence in the health and wellness market, along with its partnerships and distribution, bode well for potential high rewards. With a solid financial foundation and a promising market outlook, Synergy CHC is a promising opportunity for investors.
Bears say
Synergy CHC is facing some major challenges in its path to growth and profitability. These include the termination of its recent ME distribution deal, risks related to its balance sheet and liquidity, changes in demand for health and wellness products, increased competition, and potential changes in macroeconomic factors. Additionally, the company's stock has been weak and volatile over the past year, and its financial performance has been relatively flat. The company's recent growth has been driven by expanded distribution of its FOCUSfactor product line, but it faces risks in its expansion plans in international markets.
This aggregate rating is based on analysts' research of Synergy CHC Corp and is not a guaranteed prediction by Public.com or investment advice.
SNYR Analyst Forecast & Price Prediction
Start investing in SNYR
Order type
Buy in
Order amount
Est. shares
0 shares